Loading...
Loading...
Among the 6 tracked institutional investors we monitor, HCAT (HEALTH CATALYST INC) is held with a combined value of $19.63M across 11,548,600 shares. The largest holder is VANGUARD GROUP INC with a position worth $10.60M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$19.63M
Total Shares Held
11,548,600
Institutional Holders
6
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $10.60M | 0.00% | New |
| 2 | BlackRock, Inc. | $6.53M | 0.00% | -1.1% |
| 3 | STATE STREET CORP | $1.68M | 0.00% | -0.2% |
| 4 | FMR LLC | $466.69K | 0.00% | +5.4% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $275.68K | 0.00% | +0.0% |
| 6 | CITADEL ADVISORS LLC | $84.84K | 0.00% | +0.0% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of HCAT with a position worth $10.60M, representing 0.00% of their portfolio. In total, 6 institutional investors hold HCAT with a combined value of $19.63M.
In the most recent quarter, 1 fund opened a new position in HCAT. Additionally, 3 increased their holdings and 2 reduced their positions.
Institutional investors hold $19.63M worth of HCAT stock across 6 positions. The largest institutional holder is VANGUARD GROUP INC with $10.60M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For HCAT, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their HCAT positions.